Skip to content

DMAC

DiaMedica Therapeutics Inc.

NASDAQ · Healthcare · Biotechnology · US

$10.77
+7.70%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
43.02x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
15.15x
Price / sales
—
Price / cash flow
-18.40x

Enterprise value

Enterprise value
$537.5M
EV / sales
—
EV / EBITDA
-14.35x
EV / EBIT
-13.83x
Market cap
$580.8M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026